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Abstract
Background: Interventional pain procedures (IPPs) may be necessary for some cancer patients
when conservative treatment fails. However, many IPPs are often delayed or cancelled for cancer
patients who are referred to the pain clinic.
Methods: We retrospectively analyzed the reasons for such cancellations to identify clinically
avoidable causes of the delay in IPP.
Results: We enrolled 350 cancer patients who were referred to our pain clinic for an
IPP between March 2016 and February 2018. There were 213 (60.9%) cases that were
cancelled, among which 115 (54%) cases were potentially avoidable and 98 (46%) were unavoid-
able. The most common reasons for cancellation were patient-derived factors, which accounted
for 85 (39.9%) cases. Patient refusal was a common reason for cancellation, with 33 (15.5%) cases
attributed to this cause. The primary avoidable causes of cancellation were a recommendation
that the patient continue with their current pharmacological pain treatment, conflict with another
planned treatment, and pain characteristics that were not suitable for an IPP. Together, these
accounted for 76.5% of all avoidable cancellations.
Conclusions: Comprehensive and accurate pain assessments before IPP may result in
more favorable outcomes for the efficient use of medical resource and effective pain relief in
cancer patients.
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Introduction
Individuals with cancer are likely to experi-
ence critical pain from many sources includ-
ing the tumor, chemotherapy, radiation
therapy, and various other painful disor-
ders such as herpes zoster and degenerative
disease. These diverse forms of pain can
have a significant impact on patients’
quality of life.1–3 Although conservative
treatments such as pharmacotherapy and
physical therapy may be sufficient for
some patients, additional invasive interven-
tional pain procedures (IPPs) such as nerve
blocks and injection therapy may be bene-
ficial for certain patients. For cancer
patients, pain procedures reduce pain, and
if they are used as part of a combined reg-
imen for pain control, they can reduce daily
analgesic use and, in this way, improve a
patient’s overall quality of life.4–7
IPPs for cancer patients who are referred
to the pain clinic are often delayed or can-
celled. There are numerous reasons why pain
procedures may be delayed, including patient
preference, medical conditions, incomplete
medical evaluation, and medical personnel-
related problems. However, failure to
perform pain procedures can lead to an inef-
ficient use of medical resources and person-
nel, while a delay in pain procedures can
inconvenience patients and their families,
leading to dissatisfaction. Additionally,
delays in pain procedures can interfere with
the appropriate timing of pain management.8
The purpose of this study was to analyze
why certain cancer patients who are
referred to the pain clinic for an IPP do
not undergo the intended procedure.
Ultimately, we sought to identify clinically
avoidable reasons why IPPs are cancelled
and provide solutions and recommenda-




This retrospective study was approved by
the Institutional Review Board of
Severance Hospital, Yonsei University
Health System (No. 4-2018-0558). The
requirement for informed consent by was
waived, and patient records were anony-
mized and de-identified before analysis.
The study population consisted of cancer
patients who were referred to the pain
clinic at our institution to receive IPP
between March 2016 and February 2018.
Data were obtained from a clinical data
retrieval system at our institution and
from typical consultation sheets that are
used at the pain clinic.
Demographic and clinical data
Each patient’s medical chart was reviewed
to obtain baseline data on demographics,
cancer characteristics, and pain character-
istics when the patient presented to our
clinic. Patient demographic data included
age, sex, body mass index, and Eastern
Cooperative Oncology Group performance
status (ECOG-PS; 0, asymptomatic, fully
active; 1, symptomatic but nearly fully
ambulatory; 2, ambulatory and capable of
all self-care but unable to carry out any
work activities, <50% in bed during the
day; 3, capable of only limited self-care,
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>50% in bed but not bedbound; 4,
completely disabled, bedbound).9 The type
of primary cancer, presence of distant
metastasis, and history of chemotherapy
or radiation therapy were also investigated.
Analysis of outcome assessments
For the purpose of this study, data were col-
lected for the following variables: number of
consultations for the intended pain proce-
dure, number of cancelled cases, reason for
cancellation, and type of admission. Reasons
for failure to perform pain procedures were
placed into one of five categories: (1) Patient;
(2) Pain intervention; (3) Work-up/medical
condition; (4) Facility/Resource; and (5)
Pain physician.
In the patient category, the cancellations
were due to patient (or family member)-
directed refusal or postponement of the pro-
cedure. This category included patients who
wanted and were recommended to continue
to with their current pharmacological pain
management regimen. Because pain inter-
vention is not curative, invasive pain proce-
dures should be avoided if the pain is
tolerable. However, if there is a need for
dose correction due to severe side effects,
pain intervention could be considered,
although a period of observation before pro-
ceeding to an IPP is generally warranted.
Patients discharged early included patients
who had left without providing notification,
and if there had been earlier notification of
discharge, appropriate schedule modification
would have been performed.
The pain intervention category included
cases of incorrectly indicated IPP. Patients
with pain characteristics that were not suit-
able for intervention consisted of those
patients whose pain would not be expected
to subside with the intervention or where
the procedure would be technically impos-
sible. Examples include patients with multi-
ple bone metastases, CNS metastasis,
simple myalgia, pain due to abdominal
distension, and catheter-related pain. This
category also included patients who were
not taking proper oral medication for pain
control before attempting the intervention.7
We performed a review of recent surgical
history reports of patients who were sched-
uled for an IPP, which identified some
patients who requested a consultation for
intervention during the immediate post-
operative phase. Cancer-related pain may
be obscured immediately after surgery, and
the surgery can cause many painful side
effects. Thus, it is important that the patient
be in an adequate general condition before
undergoing any intervention. Similarly, a
recent history of another pain intervention
may raise the issue of whether the advantages
of another intervention will outweigh the risk
of side effects of their recent intervention. In
our study, interventions were cancelled for
several reasons including abnormal laborato-
ry values that were contraindicated for the
intervention and signs of infections such as
high C-reactive protein (CRP) or suspicion
of pneumonia on chest X-ray.5 Other reasons
for cancellation included contamination of
the injection site, which made performing
an intervention difficult due to the increased
likelihood of infection.
In the work-up/medical condition catego-
ry, reasons for cancellation of an IPP includ-
ed incomplete medical evaluation and
incomplete cancer work-up including patients
requiring further workup for the source of
their pain. It is important that interventions
be performed after adequate evaluation of
the cause of the pain because interventions
can be invasive and may lead to unexpected
side effects. Patients undergoing treatments
such as radiotherapy or chemotherapy
submit to a planned regimen based on their
previously treatment and are continuously re-
evaluated for intervention. Treatment in such
cases is usually palliative rather than curative.
Thus, it is reasonable that non-invasive pro-
cedures should be attempted first to avoid
potential adverse effects such as infection,
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hemorrhage, and nerve damage.10 The last
component of the work-up/medical condition
category was disease progression. Some
patients in our study were unable to partici-
pate due to an inability to maintain proper
posture, poor functional status, or increase in
tumor burden and change in medical status
such as cancer progression.
For the Facility/Resource category,
there were some instances where no proce-
dure room was available or the operating
room was full, which led to postponement
of the intervention. Another reason under
the facility/resource category was the pain
physician who referred cases where when
the surgeon was not available.
Avoidable and unavoidable causes
The reasons for cancellation were assessed
by consultation charts that were written by
residents or clinical fellows after the patient
interview and detailed chart review. The
assigned pain clinic staff confirmed the
reason for cancellation and added addition-
al explanation if necessary by calling
patients or through direct inquiry of clerical
and clinical staff. For cancellations where
the recorded reason was inconsistent with
that reported by residents or clinical fel-
lows, the assigned pain clinic staff initiated
a detailed investigation to ascertain the true
reason. Finally, a consensus was reached to
avoid assigning more than one category to a
single cancellation. This proved challenging
given the complex nature of real clinical
practice; however, two experienced pain
physicians addressed this by agreeing to
assign a root cause to a cancellation.
Cancellations were further classified as
potentially avoidable and non-avoidable.11
Avoidable cancellations were defined as
those cancellations that could have been
avoided had there been adequate review of
the patients’ medical records or better com-
munication by hospital personnel before the
patient’s consultation at the pain clinic.
Statistical analysis
Continuous variables are presented as the
mean standard deviation (SD) and cate-
gorical variables are shown as the number
(percentage). Descriptive and basic analyti-
cal statistics were used to summarize the
data. The Pareto principle, which is also
known as the 80:20 Rule or the Law of
the Vital Few and Trivial Many, was used
as a tool to identify and prioritize measures
to improve effectiveness or safety.12,13 It is
applied to quality control, and it states that
roughly 20% of the errors cause 80% of the
problems. With a small, wisely applied
effort, a considerable reduction in problems
may be reached. To prioritize future
improvement efforts, we constructed a
Pareto chart and identified the reasons
that accounted for 80% of the avoidable
IPP cancellations. All statistical analyses
were performed using the Statistical
Package for the Social Sciences, version
23.0 (IBM Corp., Armonk, NY, USA).
Ethical approval
This retrospective study was approved by the
Institutional Review Board of Severance
Hospital, Yonsei University Health System
(No. 4-2018-0558).
Results
There were 942 people who were referred to
our department during the March 2016 to
February 2018 study period. The exclusion
criteria included patients with non-cancer
pain (n¼ 412), patient preference for non-
intervention (n¼ 15), and insufficient data
(n¼ 165). Finally, 350 patients were includ-
ed in our study, of whom 137 patients
underwent an intervention and 213 patients
did not receive an intervention (Figure 1).
The overall cancellation rate was 60.9%.
Among the 213 patients with a cancelled
pain procedure, the average age was 60
years and the relative percentages of men
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and women were 41.8% and 58.2%, respec-
tively. We found that 82% had an ECOG
score that was >2, and 18% had an ECOG
score <3. The most common type of cancer
was upper gastrointestinal cancer (34%)
followed by cancers of urological, gyneco-
logic, colorectal, lung, and hematological
origins (Table 1).
The most common cancellation category
was “patient”, which comprised 85 patients
(39.9%), followed by “pain intervention”
(n¼ 68, 31.9%) and “work-up/medical con-
dition” (n¼ 57, 26.8%) (Table 2). The most
common single reason for cancellation was
“patient was recommended to continue
with their current pain management”
(n¼ 48). As shown in Table 3, other reasons
included “Patient refusal of procedure”
(n¼ 25), “other treatment planned” (n¼ 20),
and “pain characteristics not suitable for
intervention” (n¼ 20).
Among the 213 cancellations in our
study, we found that 115 were potentially
avoidable (54%) and 98 (46%) were
unavoidable (Table 3). On the basis of the
Pareto chart analysis, 76.5% of all cancel-
lations were due to patients who were rec-
ommended to continue with their current
pain management, having other treatment
planned, or having a type of pain that was
not suitable for the intervention. Thus, it
may be important to focus on decreasing
cancellation rates in these categories
(Table 4, Figure 2).
Discussion
IPP can be useful for cancer patients when
conservative treatment fails. However, such
pain procedures are often delayed or can-
celled for many of the cancer patients who
are referred to the pain clinic. In this study,
Figure 1. Flow chart of the study.
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we investigated the causes of such cancella-
tions. We found that patient-derived factors
were the most common cause of cancella-
tions, which we attributed to the fact that
the IPP focuses on conservative manage-
ment rather than fundamental treatment.
Thus, patients may be less likely to hesitate
cancelling an IPP compared with a non-
elective treatment such as surgery.
We attempted to identify the reasons for
patient refusal of IPP. Although it was dif-
ficult to analyze the exact reason for refusal
due to the retrospective nature of the study,
we found that many patients expressed
doubts regarding pain procedures due
to their non-curative nature. Another
common reason for patient refusal of IPP
was anxiety about side effects. Many
patients also expressed resistance to under-
going an invasive therapy, while others
expressed negative feelings due to not
having enough information about the pro-
cedure. Pain control for cancer patients is
managed at cancer centers, with drugs, che-
motherapy, and radiotherapy representing
more conservative treatments. However,
explanations about IPP are often only pro-
vided at the time of scheduling. Thus, it is
imperative that patients are given enough
information about the intervention because
it is an important modality for managing
cancer-related pain. Otherwise, because of
a lack of information on interventions,
many patients may become worried and
Table 1. Demographics and cancer type about failure to perform IPP.
Characteristic n¼ 213
Age (years) 59.68 13.71 (6–94)
Sex (male/female) 89 (41.8%)/124 (58.2%)














Head and neck 9 (4.2%)
Breast 7 (3.3%)
Sarcoma 4 (1.9%)
Central nervous system 3 (1.4%)
Unknown primary 3 (1.4%)
Melanoma 1 (0.5%)
Peritoneal 1 (0.5%)
All data are presented as the mean standard deviation (SD) or the number of patients (%).
IPP, interventional pain procedures; ECOG-PS, Eastern Cooperative Oncology Group performance
status; GI, gastrointestinal; GB, gallbladder.
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subsequently resistant to the procedure,
ultimately leading them to postpone
treatment.
The most common unavoidable cause of
cancellations was “Disease progression”.
When a cancer reaches an advanced stage,
patients often develop other medical prob-
lems that make IPP either difficult to per-
form or otherwise problematic due to
potential side effects. Studies1,14,15 have
shown that the incidence of pain increases
with cancer progression, and many patients
with pain that is caused by cancer are at an
advanced disease stage. Similarly, the inten-
sity of pain in advanced cancer patients is
higher in patients with poor performance
status. Consistent with this observation,
we previously showed that in patients with
pancreatic cancer, celiac plexus block has a
better analgesic effect when performed in
patients with early stage disease.16
Although not all IPP can or should be per-
formed early, timely IPP can be advanta-
geous in certain cancer patients.8,16,17
Table 2. Frequency and percentage of IPP cancellations by category.
Patient (n5 85; 39.9%)
Patient (or family) refused or postponed the proce-
dure (n¼ 33)
– Unknown reason for refusal (n¼ 12)
– Postponed the procedure (n¼ 7)
– Patient wanted to increase analgesic medication
(n¼ 5)
– Patient had anxiety about the procedure (n¼ 5)
– Patient had strong resistance to invasive therapy
(n¼ 4)
Patient was recommended to remain on the current
pain management plan (n¼ 48)
Patient discharged already (n¼ 4)
Work-up/medical condition (n557;
26.8%)
Incomplete work-up (n¼ 8)
– Incomplete medical evaluation (n¼ 5)
– Incomplete cancer work-up (n¼ 3)
Other treatment planned (n¼ 20)
– Chemotherapy or radiation therapy (n¼ 17)
– Other procedures (PTBD, PVP, EUS-CPN)
(n¼ 3)
Disease progression (n¼ 29)
– Not corporation (could not assume proper
posture) (n¼ 14)
– Poor functional status (n¼ 9)
– Tumor burden increased (n¼ 3)
– Anatomical change (could not advance
needle) (n¼ 2)
– Change in medical status (n¼ 1)
Pain intervention (n568; 31.9%)
Not indicated for the proper pain interventional
procedure (n¼ 33)
– Pain characteristics that were not suitable for
intervention (n¼ 20)
– Not taking proper oral medication (n¼ 10)
– Recent surgical history (n¼ 2)
– Recent pain intervention history (n¼ 1)
Contraindications for the intervention (n¼ 35)
– Coagulation-related problems (low platelet count,
elevated INR) (n¼ 16)
– Suspicious systemic infection signs (high fever,
recently elevated ESR/CRP, pneumonia) (n¼ 17)
– Injection site contamination (n¼ 2)
Facility/Resource (n5 2; 0.9%)
No procedure room (n¼ 2)
Pain physician (n51; 0.5%)
Surgeon not available (n¼ 1)
All data are presented as the number of patients (%).
IPP, interventional pain procedures; PTBD, percutaneous transhepatic biliary drainage; PVP, percutaneous vertebroplasty;
EUS-CPN, endoscopic ultrasound-guided celiac plexus neurolysis; CRP, C-reactive protein; INR, international normalized
ratio; ESR, erythrocyte sedimentation rate.
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The Pareto chart analysis revealed the fol-
lowing three reasons for avoidable potential
intervention cancellation: 1) the patient was
recommended to continue with their current
pain management plan; 2) the patient had
another treatment planned; and 3) the
patient’s pain characteristics were not suit-
able for intervention. Identifying these key
causes of cancellation in turn should allow
for targeted efforts to decrease cancellation
Table 4. Frequency and percentage of avoidable reasons for failure to perform IPP.
Avoidable reasons n¼ 115
Cumulative
percentage
Patient was recommended to remain on the current pain management 48 (41.7%) 41.7%
Pain characteristics were not suitable for the intervention 20 (17.4%) 59.1%
Other treatment planned 20 (17.4%) 76.5%
Not taking proper oral medication 10 (8.7%) 85.2%
Incomplete medical evaluation 5 (4.3%) 89.6%
Patient discharged already 4 (3.5%) 93.0%
Incomplete cancer work-up 3 (2.6%) 95.7%
Recent surgical history 2 (1.7%) 97.4%
No procedure room 2 (1.7%) 99.1%
Recent pain intervention history 1 (0.9%) 100.0%
All data are presented as the number of patients (%).
IPP, interventional pain procedures.
Table 3. Reasons for failure to perform IPP stratified by avoidable and unavoidable causes.




Other treatment planned (n¼ 20)
Pain characteristics not suitable for
the intervention (n¼ 20)
Not taking proper oral medication
(n¼ 10)
Incomplete medical evaluation (n¼ 5)
Incomplete cancer work-up (n¼ 3)
Recent surgical history (n¼ 2)
Recent pain intervention history (n¼ 1)
No procedure room (n¼ 2)
Coagulation-related problems (low platelet counts,
elevated INR) (n¼ 16)
Suspicious systemic infection signs (high fever, recently
elevated ESR/CRP, pneumonia) (n¼ 17)
Operator not available (n¼ 1)
Patient-related
(n¼ 116; 54.5%)
Patient was recommended to remain
on the current pain management
program (n¼ 48)
Patient discharged already (n¼ 4)
Patient refused procedure (n¼ 25)
Patient family refused procedure (n¼ 1)
Patient postponed (n¼ 7)
Not corporation (could not assume the proper pos-
ture) (n¼ 14)
Poor functional status (n¼ 9)
Tumor burden increased (n¼ 3)
Anatomical change (could not advance needle) (n¼ 2)
Change in medical status (n¼ 1)
Injection site contamination (n¼ 2)
All data are presented as the number of patients (%).
IPP, interventional pain procedures; CRP, C-reactive protein: INR, international normalized ratio; ESR, erythrocyte sed-
imentation rate.
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rates. Below, we briefly discuss the causes of
these reasons for cancellation in patients
with pancreatic cancer.
Patient was recommended to continue
with their current pharmacological pain
treatment
IPP are usually performed for patients with
pain that is intractable to other therapies.
However, when a patient’s pain is somewhat
tolerable, intervention may not be warranted
and their current therapy can be maintained.
Specifically, invasive procedures always have
potential side effects and it is advisable to
not proceed with treatment if the pain is tol-
erable. Thus, before planning an IPP, it is
imperative that a comprehensive pain assess-
ment be performed. In addition, because
individual pain scales may fluctuate on a
day-to-day basis, it is important to closely
follow the patient’s pain scale to prevent
unnecessary procedure cancellation.4,7,8
Other treatment planned
Cancellations that result from a patient
having another scheduled radiotherapy
treatment, chemotherapy treatment, or
palliative surgery were categorized as
having another treatment planned. Planned
cancer treatments, which may be more help-
ful in managing pain, should take priority
over IPP.4,18
Pain characteristics that are not suitable
for intervention
Finally, before performing an intervention,
it is important to clearly elucidate the cause
of the pain. It is important to be able to
anticipate the outcome of the procedure
and whether the specific cause of the pain
is likely to be addressed by the interven-
tion.8 Whole body pain, catheter-related
pain, abdominal discomfort due to disten-
sion, and pain due to edema, infection, or
simple myalgia are not indications for IPP.
Interventions are usually performed in
cancer patients for neurogenic pain, but
they cannot be used to address non-
cancer-related and nonspecific pain.5,8
Therefore, it is important to diligently
investigate causes of pain and rule out iden-
tifiable sources such as catheters.
Physiological and psychiatric aspects of
pain should also be evaluated.14
Figure 2. Pareto chart of the avoidable cancellation reasons.
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Limitations
There were some limitations to our study.
First, bias is unavoidable when categorizing
cases with multiple factors to a single catego-
ry. To reduce this bias, we conducted our
study using a team consensus approach.
Second, the accuracy of this study may have
been compromised due to the sole reliance
upon medical records. Finally, the approach
to pain management in our study may not be
applicable to every hospital, and thus, it is not
clear how well our results can be generalized
to other hospitals. However, there were sev-
eral clear trends with respect to the reasons
for cancellation of pain procedures.
Conclusions
Our study showed that the cancellation
ratio for IPP in cancer patients was
60.9%. We found that 54% of cancelled
cases were potentially avoidable, with the
most common reason for cancellation stem-
ming from the patient, who may have been
recommended to continue with their cur-
rent pain management, have another treat-
ment planned, or have a form of pain that
was not suitable for intervention. Our
results suggest that a more comprehensive
and accurate assessment of pain before
attempting IPP may result in more favor-
able outcomes in cancer patients, especially
as it pertains to the efficient use of medical
resources and achieving effective pain relief.
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